FDA Inspection
InvaTech Pharma Solutions, LLCInvaTech Pharma Solutions, LLC – FDA Inspection, May 13, 2026
Record Details
This FDA Inspection record concerns InvaTech Pharma Solutions, LLC, with an inspection on May 13, 2026, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 419679e5-bd47-48ed-b8c7-d81b6397a8ec
Inspection Facts
- Inspection number
- 1308318
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.170(b)Annual visual exams of drug products
- 21 CFR 211.194(c)Testing and standardization of standards et. al.
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.80(b)Handling and Storage to Prevent Contamination
- 21 CFR 211.84(b)Representative Samples
Full citation text and observation details available on the Dashboard.
Other FDA inspections of InvaTech Pharma Solutions, LLC
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 9, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 28, 2017 | VAI | New Jersey District Office | Generic Drug Evaluation |
| April 4, 2017 | Not classified | New Jersey District Office | |
| November 8, 2016 | Not classified | New Jersey District Office |
Other documents for InvaTech Pharma Solutions, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.